0000899243-20-035197.txt : 20201228 0000899243-20-035197.hdr.sgml : 20201228 20201228163023 ACCESSION NUMBER: 0000899243-20-035197 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201222 FILED AS OF DATE: 20201228 DATE AS OF CHANGE: 20201228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VIRCA NICHOLAS J CENTRAL INDEX KEY: 0001284074 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13467 FILM NUMBER: 201418663 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inhibitor Therapeutics, Inc. CENTRAL INDEX KEY: 0001042418 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 541641133 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4830 W. KENNEDY BLVD. STREET 2: SUITE 600 CITY: TAMPA STATE: FL ZIP: 33609 BUSINESS PHONE: (813) 766-2462 MAIL ADDRESS: STREET 1: 4830 W. KENNEDY BLVD. STREET 2: SUITE 600 CITY: TAMPA STATE: FL ZIP: 33609 FORMER COMPANY: FORMER CONFORMED NAME: HedgePath Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20130816 FORMER COMPANY: FORMER CONFORMED NAME: COMMONWEALTH BIOTECHNOLOGIES INC DATE OF NAME CHANGE: 19970714 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-22 0 0001042418 Inhibitor Therapeutics, Inc. INTI 0001284074 VIRCA NICHOLAS J 449 SOUTH 12TH STREET, UNIT 1705 TAMPA FL 33602 0 1 0 0 President and CEO Common Stock Option 0.031 2020-12-22 4 A 0 125000 0.00 A 2020-12-22 2030-12-22 Common Stock 125000 125000 D /s/ Nicholas J. Virca 2020-12-23